UNSPSC 51402501: Abecarnil

This classification denotes an anxiolytic with the molecular formula C24H24N2O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier IZM1PNJ3JL, chemically known as 9h-pyrido(3,4-b)indole-3-carboxylic acid, 1-(methoxymethyl)-6-(phenylmethoxy)-, 1-methylethyl ester but generally known as abecarnil, which bears US NIH Compound Identifier 65914. European Medicines Agency schedules Abecarnil in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07360MIG.

UNSPSC 51402501 Abecarnil is a Commodity code that in recent state and local activity refers to pharmaceutical products procured to support public health and emergency response initiatives. The source shows state and local governments buying naloxone (an opioid-overdose reversal medication), generic pharmaceuticals, and over-the-counter products through both direct procurement and cooperative purchasing vehicles. Issuing bodies include county health departments, state health and human services agencies, and multistate cooperative purchasing alliances. Seminole County, Florida (a county health authority) and the Texas Health and Human Services Commission and Minnesota Department of Administration (state-level health and procurement offices) are the issuing bodies represented in recent opportunities.

The three recent opportunities span Florida, Texas, and Minnesota. Seminole County's IFB 60459723LAS, posted June 30, 2026 with a response deadline of July 26, 2026, seeks 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the county community health building. The Texas HHS Commission issued RFI HHS0017013 (posted April 3, 2026, response deadline April 3, 2026) to gather market intelligence on direct-to-manufacturer prescription programs and vendor capabilities for establishing therapeutic pharmacy initiatives outside traditional pharmacy benefit manager arrangements. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration, issued RFP S1070000015802 (posted January 20, 2026, due March 26, 2026) to establish multi-award contracts for generic multi-source pharmaceuticals and OTC products distributed across state and local government facilities in Minnesota and Oregon through three authorized wholesalers; awarded vendors pay a 3 percent administrative fee and face performance penalties of $200 to $1,500 per violation for non-compliance.